Maximize Signal, Minimize Noise, Accelerate Insights
MaxYield™ maps through noise, returning a crisp, isolated ECG signal of any length. Filter for all noise and artifact at once, including baseline wander, muscle artifact, AC interference, and electrode/motion artifacts.
Quantify PQRST data sets in minutes, regardless of recording length. P, QRS, and T wave onsets, offsets, and time-series intervals are tabulated for the entire trace on a beat-by-beat basis. This includes key metrics like RR, PR, QRS, ST, QT & QTc, intervals.
In-depth labeling of all PQRST data & time-series intervals. Easily track, graph & discover trends in this data, supporting the discovery of new biomarkers.
Rapid data processing alleviates budget & overhead to focus on interpretation and publication. Spend more of your teams’ time on important, essential tasks rather than slow, repetitive & labor-intensive ECG analysis techniques.
Easily manage extensive datasets to investigate heart disease or drug impacts. MaxYield swiftly quantifies and stores large amounts of ECG data in user-friendly CSV format.
Faster Turnaround: Minimize manual tasks and shorten time-to-report for clinical trials or academic studies.
Reduced Rework: Fewer repeat tests thanks to cleaner, high-fidelity ECG data that lowers error rates.
Reliable Datasets: Standardized labeling and noise removal yield reproducible results, vital in clinical trial CRO software & publications for regulatory review.
Wearable & Telehealth Ready: Perfect for remote monitoring scenarios, delivering consistent signal quality in real-world conditions.
Efficient Report Generation: Instantly label waveforms, saving hours on manual charting.
Enhanced Discoveries: More thorough data capture supports advanced biomarker research and drug efficacy assessments.
MaxYield™ can integrate smoothly into existing clinical trial management systems. You can use the web portal on our site or integrate using API, SDK, or CDK into your own system. This seamless integration makes it an attractive clinical study solution to upgrade existing technological capabilities without disrupting ongoing operations.
The AI-driven nature of our Neural Network ensures it continuously enhances its performance with use. As it processes more data, it becomes increasingly skilled at identifying patterns and anomalies. Its accuracy is continuously improving the value of its insights. This is beneficial for long-term clinical studies and progressive research areas.
MaxYield™ harnesses cutting-edge AI and advanced signal processing technology. Our flagship innovation - our “X-Factor” - is a patent-pending Signal Mapping Algorithm that isolates and cleans ECG recordings. It delivers a beat-by-beat PQRST labeling and a clear, "neuralized" ECG signal.
This versatile algorithm is both device and application agnostic, capable of tackling complex signal processing challenges. While ECG labeling is at the core of MaxYield™, our technology extends to uncovering trends in digital biomarkers & supporting breakthroughs in cardiovascular diagnostics.
By seamlessly adapting to your unique needs, MaxYield™ empowers healthcare professionals to pursue the maximum diagnostic yield, streamline workflows, and quickly make informed decisions. With crisp signal clarity, MaxYield™ uses Gold Standard methodologies from across the cardiovascular industry.
